Telomerase

Edited by: Paul Smaglik Thomas R. Cech T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, T.R. Cech, "Telomerase catalytic subunit homologs from fission yeast and human," Science, 277:955-9, Aug. 15, 1997. (Cited in more than 220 papers since publication) Comments by Thomas R. Cech, professor of biochemistry, biophysics, and genetics at the University of Colorado Health Sciences Center, Boulder This paper is "a derivative," laughs Thomas Cech. The

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Edited by: Paul Smaglik


Thomas R. Cech
T.M. Nakamura, G.B. Morin, K.B. Chapman, S.L. Weinrich, W.H. Andrews, J. Lingner, C.B. Harley, T.R. Cech, "Telomerase catalytic subunit homologs from fission yeast and human," Science, 277:955-9, Aug. 15, 1997. (Cited in more than 220 papers since publication)

Comments by Thomas R. Cech, professor of biochemistry, biophysics, and genetics at the University of Colorado Health Sciences Center, Boulder

This paper is "a derivative," laughs Thomas Cech. The "real breakthrough" paper that made it (and its companion, see below) possible came months earlier, but has received less citation attention than either of its successors. That earlier paper reported the purification of the telomerase enzyme's catalytic subunit--the first such subunit cloned.1 "That paper was the result of four years in the cold room by Joachim Lingner," Cech recalls, adding that the skill and diligence of the then-University of Colorado at Boulder postdoc beat the odds. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies